MicroRNAs in Bladder Cancer: Expression Profiles, Biological Functions, Regulation, and Clinical Implications

被引:23
作者
Shi, Zhaoqi [1 ]
Wei, Qingxia [2 ]
Zhang, Mingxin [3 ]
She, Junjun [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gen Surg, Xian 710061, Shaanxi Provinc, Peoples R China
[2] Univ Toronto, Hosp Sick Children, Dept Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada
[3] Fourth Mil Med Univ, Tangdu Hosp, Dept Gastroenterol, Xian 710038, Shaanxi Provinc, Peoples R China
来源
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 2014年 / 24卷 / 01期
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
microRNA; bladder cancer; expression profile; biological function; regulation; clinical implication; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELL PROLIFERATION; S-TRANSFERASE-PI; UROTHELIAL CARCINOMA; DOWN-REGULATION; MESSENGER-RNAS; RISK-FACTORS; SUPPRESSOR; INHIBITION; APOPTOSIS;
D O I
10.1615/CritRevEukaryotGeneExpr.2014007798
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bladder cancer (UBC) is a common cancer worldwide and has a high rate of recurrence and progression despite systemic therapy. The molecular mechanisms of UBC are not completely understood. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles in multiple steps during the progression of UBC. Here, we review the expression profiles of miRNAs and their biological functions, regulation, and clinical implications in UBC. Either down-regulation or up-regulation of miRNAs occurs in UBC through epigenetic changes or defects of the biogenesis apparatus. Deregulation of miRNAs is involved in cell-cycle arrest, apoptosis, proliferation, metastasis, drug resistance, and other functions in UBC. A number of miRNAs, including urine miRNAs, have been associated with tumor type, stage, or patient survival, and miRNAs might be developed as diagnostic or prognostic markers. Better understanding of the roles of miRNAs in UBC will shed light on the molecular mechanisms of UBC.
引用
收藏
页码:55 / 75
页数:21
相关论文
共 129 条
[1]   The physiology and pathology of the EMT - Meeting on the epithelial-mesenchymal transition [J].
Acloque, Herve ;
Thiery, Jean Paul ;
Nieto, M. Angela .
EMBO REPORTS, 2008, 9 (04) :322-326
[2]   miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [J].
Adam, Liana ;
Zhong, Meng ;
Choi, Woonyoung ;
Qi, Wei ;
Nicoloso, Milena ;
Arora, Ameeta ;
Calin, George ;
Wang, Hua ;
Siefker-Radtke, Arlene ;
McConkey, David ;
Bar-Eli, Menashe ;
Dinney, Colin .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5060-5072
[3]  
[Anonymous], CAN UROL ASS J
[4]  
ATALA A, 2013, J UROL, V189, P385
[5]   EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update [J].
Babjuk, Marko ;
Oosterlinck, Willem ;
Sylvester, Richard ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou-Redorta, Juan ;
Roupret, Morgan .
EUROPEAN UROLOGY, 2011, 59 (06) :997-1008
[6]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[7]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[8]   microRNA-203 suppresses bladder cancer development by repressing bcl-w expression [J].
Bo, Juanjie ;
Yang, Guoliang ;
Huo, Kailing ;
Jiang, Haifeng ;
Zhang, Lianhua ;
Liu, Dongming ;
Huang, Yiran .
FEBS JOURNAL, 2011, 278 (05) :786-792
[9]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[10]   Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers [J].
Busser, Benoit ;
Sancey, Lucie ;
Josserand, Veronique ;
Niang, Carole ;
Favrot, Marie C. ;
Coll, Jean-Luc ;
Hurbin, Amandine .
MOLECULAR THERAPY, 2010, 18 (03) :528-535